ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 118 filers reported holding ANAPTYSBIO INC in Q4 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,806,357 | -19.5% | 267,615 | -8.8% | 0.00% | -100.0% |
| Q2 2023 | $5,971,122 | -53.0% | 293,566 | -49.8% | 0.00% | 0.0% |
| Q1 2023 | $12,712,910 | +41.0% | 584,234 | +100.8% | 0.00% | 0.0% |
| Q4 2022 | $9,015,497 | +239.4% | 290,916 | +179.5% | 0.00% | – |
| Q3 2022 | $2,656,000 | -0.0% | 104,085 | -20.5% | 0.00% | – |
| Q2 2022 | $2,657,000 | -40.0% | 130,892 | -26.8% | 0.00% | – |
| Q1 2022 | $4,426,000 | +480.1% | 178,921 | +714.7% | 0.00% | – |
| Q4 2021 | $763,000 | +6836.4% | 21,961 | +5417.8% | 0.00% | – |
| Q3 2021 | $11,000 | +83.3% | 398 | +70.8% | 0.00% | – |
| Q2 2021 | $6,000 | +20.0% | 233 | -2.9% | 0.00% | – |
| Q1 2021 | $5,000 | -99.9% | 240 | -99.9% | 0.00% | – |
| Q4 2020 | $4,588,000 | +45.7% | 213,410 | -0.0% | 0.00% | – |
| Q3 2020 | $3,150,000 | -51.0% | 213,514 | -25.9% | 0.00% | -100.0% |
| Q2 2020 | $6,435,000 | +130.9% | 288,066 | +46.1% | 0.00% | – |
| Q1 2020 | $2,787,000 | -2.8% | 197,228 | +11.9% | 0.00% | – |
| Q4 2019 | $2,866,000 | -98.0% | 176,313 | -95.7% | 0.00% | -100.0% |
| Q3 2019 | $141,959,000 | -37.9% | 4,057,139 | +0.1% | 0.02% | -37.0% |
| Q2 2019 | $228,702,000 | -22.7% | 4,053,558 | +0.1% | 0.03% | -22.9% |
| Q1 2019 | $295,705,000 | +15.5% | 4,047,987 | +0.9% | 0.04% | 0.0% |
| Q4 2018 | $255,973,000 | -34.8% | 4,012,735 | +2.0% | 0.04% | -20.5% |
| Q3 2018 | $392,642,000 | +56.8% | 3,935,467 | +11.7% | 0.04% | +51.7% |
| Q2 2018 | $250,384,000 | -32.6% | 3,524,549 | -1.3% | 0.03% | -34.1% |
| Q1 2018 | $371,628,000 | +11.0% | 3,570,600 | +7.4% | 0.04% | +12.8% |
| Q4 2017 | $334,789,000 | +337.0% | 3,323,953 | +51.6% | 0.04% | +333.3% |
| Q3 2017 | $76,612,000 | – | 2,192,030 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |